Nutriband Inc. Warrant
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA b… Read more
Nutriband Inc. Warrant (NTRBW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of July 2025: -0.155x
Based on the latest financial reports, Nutriband Inc. Warrant (NTRBW) has a cash flow conversion efficiency ratio of -0.155x as of July 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.31 Million) by net assets ($8.49 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nutriband Inc. Warrant - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Nutriband Inc. Warrant's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nutriband Inc. Warrant Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nutriband Inc. Warrant ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Altima Resources Ltd
PINK:ARSLF
|
0.028x |
|
VERU INC. DL-01
F:FMW
|
N/A |
|
Christina Lake Cannabis Corp
OTCQB:CLCFF
|
-0.033x |
|
Nation Group (Thailand) PCL
BK:NATION
|
0.259x |
|
Lease IT Public Company Limited
BK:LIT
|
-0.330x |
|
Pontiac Bancorp Inc
PINK:PONT
|
N/A |
|
Vo2 Cap Holding AB
ST:VO2
|
0.070x |
|
Alpcot Holding AB Series B
ST:ALPCOT-B
|
-0.037x |
Annual Cash Flow Conversion Efficiency for Nutriband Inc. Warrant (2017–2025)
The table below shows the annual cash flow conversion efficiency of Nutriband Inc. Warrant from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-01-31 | $6.43 Million | $-4.63 Million | -0.720x | -31.36% |
| 2024-01-31 | $6.44 Million | $-3.53 Million | -0.548x | -57.24% |
| 2023-01-31 | $8.57 Million | $-2.99 Million | -0.348x | -47.10% |
| 2022-01-31 | $11.86 Million | $-2.81 Million | -0.237x | -467.13% |
| 2021-01-31 | $7.11 Million | $-297.06K | -0.042x | +99.18% |
| 2020-01-31 | $175.43K | $-894.47K | -5.099x | -1009.06% |
| 2019-01-31 | $2.40 Million | $-1.11 Million | -0.460x | +39.84% |
| 2018-01-31 | $121.51K | $-92.86K | -0.764x | +88.06% |
| 2017-01-31 | $23.11K | $-147.92K | -6.401x | -- |